Roslind A - Search Results

1

Frequencies and prognostic role of KRAS and BRAF mutations in patients with localized pancreatic and ampullary adenocarcinomas.

Schultz NA, Roslind A, Christensen IJ, Horn T, Høgdall E, Pedersen LN, Kruhøffer M, Burcharth F, Wøjdemann M, Johansen JS. Schultz NA, et al. Among authors: roslind a. Pancreas. 2012 Jul;41(5):759-66. doi: 10.1097/MPA.0b013e31823cd9df. Pancreas. 2012. PMID: 22699145

2

Serum YKL-40, a new prognostic biomarker in cancer patients?

Johansen JS, Jensen BV, Roslind A, Nielsen D, Price PA. Johansen JS, et al. Among authors: roslind a. Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):194-202. doi: 10.1158/1055-9965.EPI-05-0011. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16492905 Review.

3

Is YKL-40 a new therapeutic target in cancer?

Johansen JS, Jensen BV, Roslind A, Price PA. Johansen JS, et al. Among authors: roslind a. Expert Opin Ther Targets. 2007 Feb;11(2):219-34. doi: 10.1517/14728222.11.2.219. Expert Opin Ther Targets. 2007. PMID: 17227236 Review.

4

High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival.

Roslind A, Johansen JS, Christensen IJ, Kiss K, Balslev E, Nielsen DL, Bentzen J, Price PA, Andersen E. Roslind A, et al. Int J Cancer. 2008 Feb 15;122(4):857-63. doi: 10.1002/ijc.23152. Int J Cancer. 2008. PMID: 17957792

5

YKL-40 expression in benign and malignant lesions of the breast: a methodologic study.

Roslind A, Johansen JS, Junker N, Nielsen DL, Dzaferi H, Price PA, Balslev E. Roslind A, et al. Appl Immunohistochem Mol Morphol. 2007 Dec;15(4):371-81. doi: 10.1097/01.pai.0000213146.77772.6a. Appl Immunohistochem Mol Morphol. 2007. PMID: 18091378

6

YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer.

Roslind A, Knoop AS, Jensen MB, Johansen JS, Nielsen DL, Price PA, Balslev E. Roslind A, et al. Breast Cancer Res Treat. 2008 Nov;112(2):275-85. doi: 10.1007/s10549-007-9870-7. Epub 2007 Dec 22. Breast Cancer Res Treat. 2008. PMID: 18157633

7

Subcellular localization of YKL-40 in normal and malignant epithelial cells of the breast.

Roslind A, Balslev E, Kruse H, Staergaard B, Horn T. Roslind A, et al. Ultrastruct Pathol. 2008 May-Jun;32(3):101-6. doi: 10.1080/01913120801937673. Ultrastruct Pathol. 2008. PMID: 18570155

8

YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation.

Roslind A, Johansen JS. Roslind A, et al. Methods Mol Biol. 2009;511:159-84. doi: 10.1007/978-1-59745-447-6_7. Methods Mol Biol. 2009. PMID: 19347297

9

YKL-40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis.

Richter B, Roslind A, Hesse U, Nordling J, Johansen JS, Horn T, Hansen AB. Richter B, et al. Among authors: roslind a. Histopathology. 2010 Sep;57(3):371-83. doi: 10.1111/j.1365-2559.2010.03640.x. Histopathology. 2010. PMID: 20840668

10

[Signet ring cell carcinoma of the gallbladder].

Agergaard Thing B, Roslind A, Wøjdemann M. Agergaard Thing B, et al. Among authors: roslind a. Ugeskr Laeger. 2012 Apr 2;174(14):948-9. Ugeskr Laeger. 2012. PMID: 22469166 Danish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters